INmune Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL. 

CEO
David J. Moss
CEODavid J. Moss
Employees
21
Employees21
Headquarters
Boca Raton, Florida
HeadquartersBoca Raton, Florida
Founded
2015
Founded2015
Employees
21
Employees21

INMB Key Statistics

Market cap
38.02M
Market cap38.02M
Price-Earnings ratio
-0.88
Price-Earnings ratio-0.88
Dividend yield
Dividend yield
Average volume
1.80M
Average volume1.80M
High today
$1.59
High today$1.59
Low today
$1.42
Low today$1.42
Open price
$1.48
Open price$1.48
Volume
3.40M
Volume3.40M
52 Week high
$11.64
52 Week high$11.64
52 Week low
$1.09
52 Week low$1.09

Stock Snapshot

With a market cap of 38.02M, INmune Bio(INMB) trades at $1.49. The stock has a price-to-earnings ratio of -0.88.

On 2026-06-27, INmune Bio(INMB) stock traded between a low of $1.42 and a high of $1.59. Shares are currently priced at $1.49, which is +4.9% above the low and -6.3% below the high.

INmune Bio(INMB) shares are trading with a volume of 3.4M, against a daily average of 1.8M.

During the past year, INmune Bio(INMB) stock moved between $1.09 at its lowest and $11.64 at its peak.

During the past year, INmune Bio(INMB) stock moved between $1.09 at its lowest and $11.64 at its peak.

INMB News

Investing.com 2d
INmune Bio receives UK regulatory approval for RDEB treatment plan - Investing.com

...

INmune Bio receives UK regulatory approval for RDEB treatment plan - Investing.com
TipRanks 2d
INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan

INmune Bio (INMB) announced that the UK Medicines & Healthcare products Regulatory Agency, or MHRA, has approved the pediatric investigation plan, or PIP, for E...

TipRanks 4d
INmune Bio Advances Ebstrocel Toward UK Conditional Approval

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

People also own

Based on the portfolios of people who own INMB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.